FMR LLC cut its stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 4.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,825,724 shares of the health services provider's stock after selling 136,944 shares during the period. FMR LLC owned 4.24% of Universal Health Services worth $647,119,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the stock. Point72 Asset Management L.P. lifted its holdings in shares of Universal Health Services by 362.3% during the second quarter. Point72 Asset Management L.P. now owns 322,626 shares of the health services provider's stock worth $59,663,000 after purchasing an additional 252,846 shares during the period. Marshall Wace LLP raised its position in Universal Health Services by 357.9% during the 2nd quarter. Marshall Wace LLP now owns 261,221 shares of the health services provider's stock worth $48,308,000 after buying an additional 204,178 shares during the last quarter. Mackenzie Financial Corp lifted its stake in Universal Health Services by 408.2% during the 2nd quarter. Mackenzie Financial Corp now owns 140,561 shares of the health services provider's stock valued at $25,994,000 after acquiring an additional 112,902 shares during the period. Los Angeles Capital Management LLC boosted its holdings in Universal Health Services by 102.0% in the third quarter. Los Angeles Capital Management LLC now owns 210,926 shares of the health services provider's stock valued at $48,304,000 after purchasing an additional 106,517 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in Universal Health Services during the second quarter worth about $18,031,000. Institutional investors and hedge funds own 86.05% of the company's stock.
Universal Health Services Price Performance
Shares of NYSE:UHS traded up $1.50 during midday trading on Friday, hitting $205.00. The company had a trading volume of 375,780 shares, compared to its average volume of 686,370. Universal Health Services, Inc. has a twelve month low of $133.70 and a twelve month high of $243.25. The stock has a market cap of $13.52 billion, a price-to-earnings ratio of 13.49, a price-to-earnings-growth ratio of 0.65 and a beta of 1.29. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.39 and a quick ratio of 1.28. The business's 50-day simple moving average is $215.48 and its 200-day simple moving average is $206.91.
Universal Health Services (NYSE:UHS - Get Free Report) last announced its quarterly earnings data on Thursday, October 24th. The health services provider reported $3.71 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.75 by ($0.04). Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The firm had revenue of $3.96 billion during the quarter, compared to analysts' expectations of $3.90 billion. During the same period in the prior year, the company posted $2.55 EPS. The company's revenue for the quarter was up 11.3% compared to the same quarter last year. On average, research analysts predict that Universal Health Services, Inc. will post 15.93 earnings per share for the current year.
Universal Health Services Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Tuesday, December 3rd will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date of this dividend is Tuesday, December 3rd. Universal Health Services's dividend payout ratio is presently 5.32%.
Wall Street Analysts Forecast Growth
UHS has been the subject of a number of recent analyst reports. KeyCorp started coverage on shares of Universal Health Services in a report on Friday, October 11th. They issued a "sector weight" rating for the company. Cantor Fitzgerald reiterated a "neutral" rating and set a $219.00 price target on shares of Universal Health Services in a research report on Friday, October 25th. TD Cowen cut their price objective on Universal Health Services from $275.00 to $251.00 and set a "buy" rating for the company in a research report on Tuesday. Royal Bank of Canada decreased their target price on Universal Health Services from $222.00 to $211.00 and set a "sector perform" rating on the stock in a research report on Monday, October 28th. Finally, StockNews.com lowered shares of Universal Health Services from a "strong-buy" rating to a "buy" rating in a report on Saturday, November 9th. Six investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Universal Health Services has an average rating of "Moderate Buy" and a consensus target price of $225.50.
View Our Latest Research Report on UHS
About Universal Health Services
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Featured Stories
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.